Growth Metrics

Opus Genetics (IRD) Profit After Tax (2022 - 2024)

Opus Genetics (IRD) has disclosed Profit After Tax for 6 consecutive years, with -$40.4 million as the latest value for Q4 2021.

  • On a quarterly basis, Profit After Tax changed N/A to -$40.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$56.7 million, a N/A change, with the full-year FY2022 number at $17.9 million, up 131.55% from a year prior.
  • Profit After Tax was -$40.4 million for Q4 2021 at Opus Genetics, down from -$1.9 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$40.4 million in Q4 2021 to a low of -$40.4 million in Q4 2021.